151 related articles for article (PubMed ID: 10898572)
21. Evaluation of Candidate Theranostics for
Abou DS; Longtine M; Fears A; Benabdallah N; Unnerstall R; Johnston H; Shim K; Hasson A; Zhang H; Ulmert D; Mangin F; Ozen S; Raibaut L; Brandès S; Meyer M; Chambron JC; Tatum DS; Magda D; Wahl RL; Thorek DLJ
J Nucl Med; 2023 Jul; 64(7):1062-1068. PubMed ID: 37142300
[No Abstract] [Full Text] [Related]
22. Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates.
Dadwal M; Kang CS; Song HA; Sun X; Dai A; Baidoo KE; Brechbiel MW; Chong HS
Bioorg Med Chem Lett; 2011 Dec; 21(24):7513-5. PubMed ID: 22047687
[TBL] [Abstract][Full Text] [Related]
23. The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy.
Geerlings MW; Kaspersen FM; Apostolidis C; van der Hout R
Nucl Med Commun; 1993 Feb; 14(2):121-5. PubMed ID: 8429990
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes.
Wilson JJ; Ferrier M; Radchenko V; Maassen JR; Engle JW; Batista ER; Martin RL; Nortier FM; Fassbender ME; John KD; Birnbaum ER
Nucl Med Biol; 2015 May; 42(5):428-438. PubMed ID: 25684650
[TBL] [Abstract][Full Text] [Related]
25. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.
Kang CS; Wu N; Chen Y; Sun X; Bandara N; Liu D; Lewis MR; Rogers BE; Chong HS
J Inorg Biochem; 2016 Jan; 154():60-6. PubMed ID: 26583705
[TBL] [Abstract][Full Text] [Related]
26. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.
Vera DR; Eigner S; Beran M; Henke KE; Laznickova A; Laznicek M; Melichar F; Chinol M
Cancer Biother Radiopharm; 2011 Jun; 26(3):287-97. PubMed ID: 21711096
[TBL] [Abstract][Full Text] [Related]
27. Head-to-head comparison of three chelates reveals DOTAGA promising for
Sudo H; Tsuji AB; Sugyo A; Harada Y; Nagayama S; Katagiri T; Nakamura Y; Higashi T
Cancer Sci; 2023 Dec; 114(12):4677-4690. PubMed ID: 37781962
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.
Milenic DE; Roselli M; Mirzadeh S; Pippin CG; Gansow OA; Colcher D; Brechbiel MW; Schlom J
Cancer Biother Radiopharm; 2001 Apr; 16(2):133-46. PubMed ID: 11385960
[TBL] [Abstract][Full Text] [Related]
29. Rapid and efficient production of radiolabeled antibody conjugates using vacuum diafiltration guided by mathematical modeling.
Bartlett DW; Colcher D; Raubitschek AA
Bioconjug Chem; 2008 Sep; 19(9):1927-37. PubMed ID: 18720981
[TBL] [Abstract][Full Text] [Related]
30. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
31. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
Lewis MR; Raubitschek A; Shively JE
Bioconjug Chem; 1994; 5(6):565-76. PubMed ID: 7873659
[TBL] [Abstract][Full Text] [Related]
32. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Nilsson R; Sandberg BE; Brechbiel M
Bioconjug Chem; 2002; 13(5):1079-92. PubMed ID: 12236790
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates.
Somayaji VV; Guay V; Peng Z; Sykes TR; Noujaim AA
Q J Nucl Med; 1995 Dec; 39(4):300-10. PubMed ID: 8624793
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.
Ogawa K; Kawashima H; Kinuya S; Shiba K; Onoguchi M; Kimura H; Hashimoto K; Odani A; Saji H
Ann Nucl Med; 2009 Dec; 23(10):843-8. PubMed ID: 19921351
[TBL] [Abstract][Full Text] [Related]
35. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
Mohsin H; Jia F; Sivaguru G; Hudson MJ; Shelton TD; Hoffman TJ; Cutler CS; Ketring AR; Athey PS; Simón J; Frank RK; Jurisson SS; Lewis MR
Bioconjug Chem; 2006; 17(2):485-92. PubMed ID: 16536481
[TBL] [Abstract][Full Text] [Related]
36. H
Wharton L; Jaraquemada-Peláez MG; Zhang C; Zeisler J; Rodríguez-Rodríguez C; Osooly M; Radchenko V; Yang H; Lin KS; Bénard F; Schaffer P; Orvig C
Bioconjug Chem; 2022 Oct; 33(10):1900-1921. PubMed ID: 36126334
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
[TBL] [Abstract][Full Text] [Related]
38. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
[TBL] [Abstract][Full Text] [Related]
39. Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study.
Guleria M; Das T; Kumar C; Sharma R; Amirdhanayagam J; Sarma HD; Dash A
Anticancer Agents Med Chem; 2018; 18(1):146-153. PubMed ID: 28745238
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
